ADMA BIOLOGICS, INC.: capex
| Value | {"amount": 1945000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-03-31 |
| Status | current |
| Entity | ADMA BIOLOGICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:04.216257+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9c708398-a829-47d6-853a-5e0e769ac695
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-24-025226Retrieved: 2026-08-19T13:07:04.216257+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001368514/capex/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9c708398-a829-47d6-853a-5e0e769ac695
History
- supersedes {"amount": 1944596, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001140361-23-023920)